Unresectable Uterine Corpus Leiomyosarcoma
1 clinical trials · Condition
◉ Watch Unresectable Uterine Corpus Leiomyosarcoma
| Record | Firm | Date |
|---|---|---|
| Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working (NCT05432791) | National Cancer Institute (NCI) | 2023-03-30 |
Track Unresectable Uterine Corpus Leiomyosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.